Current portfolio

XyloCor Therapeutics

US biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease

  • Sektor
    Healthcare
  • Land
    United States
  • Fond
    LSP 6
  • Entry
    2018
  • Web
Logo
EQT logo